BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Treatment
3289 results:

  • 1. Short- and long-term outcome differences between patients undergoing left and right colon cancer surgery: cohort study.
    Kuliavas J; Marcinkevičiūtė K; Baušys A; Bičkaitė K; Baušys R; Abeciūnas V; Degutytė AE; Kryžauskas M; Stratilatovas E; Dulskas A; Poškus T; Strupas K
    Int J Colorectal Dis; 2024 May; 39(1):66. PubMed ID: 38702488
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Circulating-tumour DNA methylation of HAND1 gene: a promising biomarker in early detection of colorectal cancer.
    Shavali M; Moradi A; Tahmaseb M; Mohammadian K; Ganji SM
    BMC Med Genomics; 2024 Apr; 17(1):117. PubMed ID: 38689296
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Correlations between preoperative statin treatment with short- and long-term survival following colorectal cancer surgery: a propensity score-matched national cohort study.
    Löffler L; Gögenur I; Gögenur M
    Int J Colorectal Dis; 2024 Apr; 39(1):60. PubMed ID: 38676763
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical impact of panel gene sequencing on therapy of advanced cancers of the digestive system: a retrospective, single center study.
    Dreikhausen L; Klupsch A; Wiest I; Xiao Q; Schulte N; Betge J; Boch T; Brochhausen C; Gaiser T; Hofheinz RD; Ebert M; Zhan T
    BMC Cancer; 2024 Apr; 24(1):526. PubMed ID: 38664720
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The effect of metabolism-related lifestyle and clinical risk factors on digestive system cancers in East Asian populations: a two-sample Mendelian randomization analysis.
    Cai X; Li X; Liang C; Zhang M; Dong Z; Yu W
    Sci Rep; 2024 Apr; 14(1):9474. PubMed ID: 38658636
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Reassessment of practice of Chinese surgeons since introduction of the watch and wait strategy after neoadjuvant therapy for rectal cancer].
    Zhao MH; Sun TT; Wang L; Huang YL; Xie XY; Lu Y; Zhao GH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):383-394. PubMed ID: 38644244
    [No Abstract]    [Full Text] [Related]  

  • 7. [Long-term outcome of patients with rectal cancer who achieve complete or near complete clinical responses after neoadjuvant therapy: a multicenter registry study of data from the Chinese Watch and Wait Database].
    Zhao YM; Wang WH; Zhang W; Wang L; Li S; Wang JW; Liao LE; Yu GY; Sun Z; Qu YL; Gong Y; Lu Y; Wu T; Li YF; Wang Q; Zhao GH; Xiao Y; Ding PR; Zhang Z; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):372-382. PubMed ID: 38644243
    [No Abstract]    [Full Text] [Related]  

  • 8. Characteristics and outcomes of cancer patients admitted to intensive care units in cancer specialized hospitals in China.
    Liu W; Zhou D; Zhang L; Huang M; Quan R; Xia R; Ye Y; Zhang G; Shen Z;
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):205. PubMed ID: 38642154
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Urolithin A affects cellular migration and modulates matrix metalloproteinase expression in colorectal cancer cells.
    El-Wetidy MS; Rady MI; Rady I; Helal H
    Cell Biochem Funct; 2024 Apr; 42(3):e4019. PubMed ID: 38622949
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor-stroma ratio in colon cancer.
    Polack M; Smit MA; van Pelt GW; Roodvoets AGH; Meershoek-Klein Kranenbarg E; Putter H; Gelderblom H; Crobach ASLP; Terpstra V; Petrushevska G; Gašljević G; Kjær-Frifeldt S; de Cuba EMV; Bulkmans NWJ; Vink GR; Al Dieri R; Tollenaar RAEM; van Krieken JHJM; Mesker WE;
    ESMO Open; 2024 Apr; 9(4):102988. PubMed ID: 38613913
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. B7-H3 Expression in Breast cancer and Brain Metastasis.
    Joshi V; Beecher K; Lim M; Stacey A; Feng Y; Jat PS; Duijf PHG; Simpson PT; Lakhani SR; McCart Reed AE
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612786
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy for borderline resectable and unresectable colorectal liver metastases: phase II feasibility study.
    Krul MF; Kok NFM; Osmani H; Buisman FE; Groot Koerkamp B; Grunhagen DJ; Verhoef C; Mostert B; Snaebjornsson P; Westerink B; Klompenhouwer EG; Donswijk ML; Ruers TJM; Douma JAJ; van Blijderveen N; Kingham TP; D'Angelica MI; Kemeny NE; Bolhuis K; Buffart TE; Kuhlmann KFD
    Br J Surg; 2024 Apr; 111(4):. PubMed ID: 38608150
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study.
    Elez E; Cubillo A; Alfonso PG; Middleton MR; Chau I; Alkuzweny B; Alcasid A; Zhang X; Van Cutsem E
    BMC Cancer; 2024 Apr; 24(1):446. PubMed ID: 38600471
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Spouses of patients treated for colon cancer: identification of key caregiver skills using the Delphi method.
    Le Roux E; Meunier-Beillard N; Simonel C; Omorou A; Lejeune C
    Support Care Cancer; 2024 Apr; 32(4):263. PubMed ID: 38564042
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer.
    D'Agostino E; Mastrodomenico L; Ponzoni O; Baldessari C; Piombino C; Pipitone S; Giuseppa Vitale M; Sabbatini R; Dominici M; Toss A
    Cancer Treat Rev; 2024 May; 126():102723. PubMed ID: 38555857
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Furanocoumarin compounds isolated from
    Pengnam S; Jitkaroon W; Srisuphan R; Wongprayoon P; Rayanil KO; Charoensuksai P
    Acta Pharm; 2024 Mar; 74(1):67-79. PubMed ID: 38554381
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.
    Kim S; Ghiringhelli F; de la Fouchardière C; Evesque L; Smith D; Badet N; Samalin E; Lopez-Trabada Ataz D; Parzy A; Desramé J; Baba Hamed N; Buecher B; Tougeron D; Bouché O; Dahan L; Chibaudel B; El Hajbi F; Mineur L; Dubreuil O; Ben Abdelghani M; Pecout S; Bibeau F; Herfs M; Garcia ML; Meurisse A; Vernerey D; Taïeb J; Borg C
    Lancet Oncol; 2024 Apr; 25(4):518-528. PubMed ID: 38547895
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Extended Right Hepatectomy following Clearance of the Left Liver Lobe and Portal Vein Embolization for Curatively Intended treatment of Extensive Bilobar colorectal Liver Metastases: A Single-Center Case Series.
    Knitter S; Sauer L; Hillebrandt KH; Moosburner S; Fehrenbach U; Auer TA; Raschzok N; Lurje G; Krenzien F; Pratschke J; Schöning W
    Curr Oncol; 2024 Feb; 31(3):1145-1161. PubMed ID: 38534918
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Management of non-curative endoscopic resection of T1 colon cancer.
    Bernklev L; Nilsen JA; Augestad KM; Holme Ø; Pilonis ND
    Best Pract Res Clin Gastroenterol; 2024 Feb; 68():101891. PubMed ID: 38522886
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer.
    Levy A; Morel D; Texier M; Sun R; Durand-Labrunie J; Rodriguez-Ruiz ME; Racadot S; Supiot S; Magné N; Cyrille S; Louvel G; Massard C; Verlingue L; Bouquet F; Bustillos A; Bouarroudj L; Quevrin C; Clémenson C; Mondini M; Meziani L; Tselikas L; Bahleda R; Hollebecque A; Deutsch E
    Mol Cancer; 2024 Mar; 23(1):61. PubMed ID: 38519913
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 165.